Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • FDA

    Tag: fda

    You Searched For "FDA"
    FDA approves intravenous version of Tesaro drug for chemotherapy nausea

    FDA approves intravenous version of Tesaro drug for chemotherapy nausea

    Ruby Khatun Khatun28 Oct 2017 9:44 AM IST
    Tesaro Inc said on Wednesday that the U.S. Food and Drug Administration (FDA) approved an intravenous version of its drug to treat...
    Natco pharma partner Mylan gets USFDA nod for multiple sclerosis injection

    Natco pharma partner Mylan gets USFDA nod for multiple sclerosis injection

    Ruby Khatun Khatun4 Oct 2017 10:55 AM IST
    New Delhi: The US Food and Drug Administration has granted approval to drug major Natco Pharma's marketing partner Mylan's Glatiramer Acetate...
    FDA acts to encourage generic competition for complex drugs

    FDA acts to encourage generic competition for complex drugs

    Ruby Khatun Khatun4 Oct 2017 10:46 AM IST
    TRENTON, N.J.: The U.S. Food and Drug Administration (FDA) is opening a new front in its efforts to reduce high drug prices by encouraging the...
    FDA approves Novo Nordisk fast-acting insulin Fiasp

    FDA approves Novo Nordisk fast-acting insulin Fiasp

    Ruby Khatun Khatun4 Oct 2017 9:57 AM IST
    The U.S. Food and Drug Administration (FDA) on Friday approved Novo Nordisk's fast-acting insulin to treat diabetes.The product, known as Fiasp, is...
    Roche Perjeta regimen gets FDA priority review in breast cancer

    Roche Perjeta regimen gets FDA priority review in breast cancer

    Ruby Khatun Khatun4 Oct 2017 9:20 AM IST
    ZURICH: The U.S. Food and Drug Administration (FDA) has granted a priority review for Roche's Perjeta in combination with Herceptin and chemotherapy...
    FDA grants new indication for BRIVIACT for partial-onset seizures in patients 16 years and older with epilepsy.

    FDA grants new indication for BRIVIACT for partial-onset seizures in patients 16 years and older with epilepsy.

    Ruby Khatun Khatun19 Sept 2017 9:24 AM IST
    ATLANTA and BRUSSELS: UCB announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for...
    Drugmaker Teva hires Lundbeck CEO Schultz to restore its health

    Drugmaker Teva hires Lundbeck CEO Schultz to restore its health

    Ruby Khatun Khatun12 Sept 2017 9:47 AM IST
    JERUSALEM/COPENHAGEN: Teva poached Lundbeck's Kare Schultz as its new chief executive on Monday, handing the drugs industry veteran the urgent task of...
    Novo Nordisk settles US probe over diabetes drug for nearly 58.7 million dollar

    Novo Nordisk settles US probe over diabetes drug for nearly 58.7 million dollar

    Ruby Khatun Khatun7 Sept 2017 10:48 AM IST
    Novo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker's sales staff downplayed the importance of U.S. Food and Drug...
    Maha FDA cancelled 58 manufacturing licenses, suspended 145 for non-compliance

    Maha FDA cancelled 58 manufacturing licenses, suspended 145 for non-compliance

    Ruby Khatun Khatun28 Aug 2017 4:33 PM IST
    New Delhi: Maharashtra FDA had carried out 2,540 inspections on 2,493 manufacturing units across the state since April 2016 till date and on the basis...
    FDA approves Mavyret for Hepatitis C

    FDA approves Mavyret for Hepatitis C

    Ruby Khatun Khatun10 Aug 2017 9:45 AM IST
    The U.S. Food and Drug Administration (FDA) approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV)...
    Tobacco companies diversify into pharmaceuticals

    Tobacco companies diversify into pharmaceuticals

    Ruby Khatun Khatun21 July 2017 9:49 AM IST
    Tobacco companies claim to be developing and selling merchandise to help cigarette smokers quit, but health researchers accuse the industry of trying...
    FDA rejects Coherus

    FDA rejects Coherus' biosimilar for Amgen's Neulasta

    Ruby Khatun Khatun13 Jun 2017 9:12 AM IST
    n" style="transform: translate3d(0px, 0px, 0px);"Coherus BioSciences Inc said on Monday the U.S. Food and Drug Administration (FDA) denied the...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok